Cargando…

Oversight and review of clinical gene transfer protocols : assessing the role of the Recombinant DNA Advisory Committee /

Gene transfer research is a rapidly advancing field that involves the introduction of a genetic sequence into a human subject for research or diagnostic purposes. Clinical gene transfer trials are subject to regulation by the U.S. Food and Drug Administration (FDA) at the federal level and to oversi...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Autor Corporativo: Institute of Medicine (U.S.). Committee on the Independent Review and Assessment of the Activities of the NIH Recombinant DNA Advisory Committee (Autor)
Otros Autores: Lenzi, Rebecca N. (Editor ), Altevogt, Bruce M. (Editor ), Gostin, Lawrence O. (Lawrence Ogalthorpe) (Editor )
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Washington, D.C. : National Academies Press, [2014]
Temas:
Acceso en línea:Texto completo

MARC

LEADER 00000cam a2200000 i 4500
001 EBOOKCENTRAL_ocn881654717
003 OCoLC
005 20240329122006.0
006 m o d
007 cr bn|||||||||
008 140516s2014 dcua obt 000 0 eng
040 |a NLM  |b eng  |e rda  |e pn  |c NLM  |d COO  |d MMU  |d UCNAP  |d E7B  |d YDXCP  |d N$T  |d VT2  |d EBLCP  |d OCLCA  |d OCLCQ  |d OCLCO  |d AGLDB  |d ZCU  |d MERUC  |d OCLCQ  |d OCLCO  |d OCLCA  |d U3W  |d COCUF  |d OCLCF  |d STF  |d OCLCQ  |d VTS  |d ICG  |d OCLCQ  |d OCLCO  |d WYU  |d REC  |d DKC  |d OCLCQ  |d M8D  |d OCLCQ  |d OCLCO  |d NLM  |d OCLCO  |d AJS  |d OCLCO  |d OCLCA  |d OCLCO  |d OCLCQ  |d OCLCO  |d OCLCL 
016 7 |a 101633141  |2 DNLM 
019 |a 870331857  |a 929505316  |a 932320630  |a 961541366  |a 962566559  |a 978674798  |a 978899035  |a 987730053  |a 1011956175  |a 1018001798  |a 1022048230  |a 1023009131  |a 1038733641  |a 1044951806  |a 1048747505 
020 |a 9780309296625 
020 |a 0309296625 
020 |a 9780309296632 
020 |a 0309296633 
029 0 |a NLM  |b 101633141 
029 1 |a AU@  |b 000053138928 
029 1 |a DEBBG  |b BV042794594 
029 1 |a DEBBG  |b BV043624923 
029 1 |a DEBSZ  |b 429942125 
035 |a (OCoLC)881654717  |z (OCoLC)870331857  |z (OCoLC)929505316  |z (OCoLC)932320630  |z (OCoLC)961541366  |z (OCoLC)962566559  |z (OCoLC)978674798  |z (OCoLC)978899035  |z (OCoLC)987730053  |z (OCoLC)1011956175  |z (OCoLC)1018001798  |z (OCoLC)1022048230  |z (OCoLC)1023009131  |z (OCoLC)1038733641  |z (OCoLC)1044951806  |z (OCoLC)1048747505 
042 |a pcc 
043 |a n-us--- 
050 4 |a QH448.4 
060 0 0 |a 2014 I-979 
060 0 0 |a QU 550 
072 7 |a SCI  |x 027000  |2 bisacsh 
082 0 4 |a 576.5  |2 23 
049 |a UAMI 
110 2 |a Institute of Medicine (U.S.).  |b Committee on the Independent Review and Assessment of the Activities of the NIH Recombinant DNA Advisory Committee,  |e author. 
245 1 0 |a Oversight and review of clinical gene transfer protocols :  |b assessing the role of the Recombinant DNA Advisory Committee /  |c Committee on the Independent Review and Assessment of the Activities of the NIH Recombinant DNA Advisory Committee ; Board on Health Sciences Policy ; Rebecca N. Lenzi, Bruce M. Altevogt, Lawrence O. Gostin, editors ; Institute of Medicine of the National Academies. 
264 1 |a Washington, D.C. :  |b National Academies Press,  |c [2014] 
300 |a 1 online resource (1 PDF file (xviii, 116 pages :  |b illustrations 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
500 |a Title from PDF title page. 
504 |a Includes bibliographical references. 
520 3 |a Gene transfer research is a rapidly advancing field that involves the introduction of a genetic sequence into a human subject for research or diagnostic purposes. Clinical gene transfer trials are subject to regulation by the U.S. Food and Drug Administration (FDA) at the federal level and to oversight by institutional review boards (IRBs) and institutional biosafety committees (IBCs) at the local level before human subjects can be enrolled. In addition, at present all researchers and institutions funded by the National Institutes of Health (NIH) are required by NIH guidelines to submit human gene transfer protocols for advisory review by the NIH Recombinant DNA Advisory Committee (RAC). Some protocols are then selected for individual review and public discussion. Oversight and Review of Clinical Gene Transfer Protocols provides an assessment of the state of existing gene transfer science and the current regulatory and policy context under which research is investigated. This report assesses whether the current oversight of individual gene transfer protocols by the RAC continues to be necessary and offers recommendations concerning the criteria the NIH should employ to determine whether individual protocols should receive public review. The focus of this report is on the standards the RAC and NIH should use in exercising its oversight function. Oversight and Review of Clinical Gene Transfer Protocols will assist not only the RAC, but also research institutions and the general public with respect to utilizing and improving existing oversight processes. 
536 |a This project was supported by Contract/Grant No. HHSN263201200074I between the National Academy of Sciences and the National Institutes of Health. Any opinions, findings, conclusions, or recommendations expressed in this publication are those of the authors and do not necessarily reflect the views of the organizations or agencies that provided support for the project. 
588 0 |a Version viewed July 9, 2014. 
505 0 |a Gene transfer research : the evolution of the clinical science -- Oversight of gene transfer research -- Evolution of oversight of emerging clinical research. 
590 |a ProQuest Ebook Central  |b Ebook Central Academic Complete 
610 2 0 |a National Institutes of Health (U.S.).  |b Recombinant DNA Advisory Committee. 
610 2 2 |a National Institutes of Health (U.S.)  |b Recombinant DNA Advisory Committee 
610 2 7 |a National Institutes of Health (U.S.).  |b Recombinant DNA Advisory Committee  |2 fast 
650 0 |a Institutional review boards (Medicine)  |z United States  |x Evaluation. 
650 0 |a Genetics  |x Research  |x Moral and ethical aspects  |z United States. 
650 0 |a Genetics  |x Research  |x Health aspects  |z United States. 
650 0 |a Recombinant DNA  |x Research  |x Moral and ethical aspects  |z United States. 
650 0 |a Recombinant DNA  |x Research  |x Health aspects  |z United States. 
650 0 |a Genetic transformation  |x Research  |x Moral and ethical aspects  |z United States. 
650 0 |a Genetic transformation  |x Research  |x Health aspects  |z United States. 
650 1 2 |a Gene Transfer Techniques  |x standards 
650 2 2 |a Genetic Research 
650 2 2 |a Advisory Committees  |x standards 
650 2 2 |a Clinical Trials as Topic  |x standards 
650 6 |a Comités d'éthique de la recherche  |z États-Unis  |x Évaluation. 
650 7 |a SCIENCE  |x Life Sciences  |x Evolution.  |2 bisacsh 
650 7 |a Genetics  |x Research  |x Moral and ethical aspects  |2 fast 
651 7 |a United States  |2 fast  |1 https://id.oclc.org/worldcat/entity/E39PBJtxgQXMWqmjMjjwXRHgrq 
655 2 |a Guideline 
700 1 |a Lenzi, Rebecca N.,  |e editor. 
700 1 |a Altevogt, Bruce M.,  |e editor. 
700 1 |a Gostin, Lawrence O.  |q (Lawrence Ogalthorpe),  |e editor.  |1 https://id.oclc.org/worldcat/entity/E39PBJjXj3gcXYGf6Rhy8Ggh73 
776 0 8 |i Print version:  |t Oversight and review of clinical gene transfer protocols.  |d Washington, D.C. : National Academies Press, 2014  |z 0309296625  |w (OCoLC)875999370 
856 4 0 |u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=3564285  |z Texto completo 
938 |a EBL - Ebook Library  |b EBLB  |n EBL3564285 
938 |a ebrary  |b EBRY  |n ebr10863709 
938 |a EBSCOhost  |b EBSC  |n 867720 
938 |a YBP Library Services  |b YANK  |n 11864916 
994 |a 92  |b IZTAP